Cite
HARVARD Citation
Carpenter, E. et al. (2019). Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib‐resistant BRAFV600E mutation bearing metastatic melanoma cells. Molecular carcinogenesis. 58 (9), pp. 1680-1690. [Online].